Skip to main content

Advertisement

SpringerLink
Log in

Health Disparities and Vitamin D

  • Original Paper
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Research over the last two to three decades has slowly demonstrated that Vitamin D, a long neglected and unappreciated hormone, is of profound importance to human health and survival. Vitamin D begins its synthesis in human skin with ultraviolet B radiation (UVB) from the sun. Melanin is a potent UVB blocker, protecting the skin from the high intensity sunlight found on the tropical savannah into which humans evolved, but not impairing the skin’s ability to synthesize generous quantities of vitamin D there. Adaptation to environmental availability of UVB radiation from the sun appears to explain the variation in skin melanin content in indigenous human populations around the world. Evidence shows populations in the United States have mean vitamin D levels that are associated with the relative amount of melanin in the skin in those populations, and that humans with insufficient levels of vitamin D suffer disproportionately from the diseases associated with health disparities. The differences in incidence and severity of cardiovascular diseases, the most common cancers, diabetes, tuberculosis, conditions associated with infant mortality, and total mortality in populations associated with health disparities in the United States are explored in this chapter. Indeed, the magnitude of the disparity in diseases associated with “health disparities,” related to the effect of vitamin D on those diseases, is such that eliminating the differences in vitamin D levels between the populations would appear to virtually eliminate the health disparities between them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17
Fig. 18
Fig. 19
Fig. 20
Fig. 21
Fig. 22

Similar content being viewed by others

References

  1. From the home page of the CDC OMHD website. http://www.cdc.gov/omhd/AMH/AMH.htm. Accessed 19 Aug 2008.

  2. From the US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Healthy People 2010 Website. http://www.healthypeople.gov. Accessed 19 Aug 2008.

  3. Lawson E, Young A. Health care revival renews, rekindles, and revives. Am J Public Health. 2002;92:177–9.

    Article  PubMed  Google Scholar 

  4. Mosekilde L. Vitamin D in the elderly. Clin Endocrinol. 2005;62(3):265–81.

    Article  CAS  Google Scholar 

  5. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116:634–9.

    Article  PubMed  CAS  Google Scholar 

  6. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28.

    PubMed  CAS  Google Scholar 

  7. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med. 2007;167:1159–65. (Data from NHANES III).

    Article  PubMed  CAS  Google Scholar 

  8. Mathews TJ, MacDorman M. Infant mortality statistics from the 2004 linked birth/infant death data set. NVSR. 2007;55(14):1–32.

    CAS  Google Scholar 

  9. Alexander G, Kogan M, Bader D, Carlo W, Allen M, Mor J. US birth weight/gestational age-specific neonatal mortality: 1995–1997 rates for Whites, Hispanics, and Blacks. Pediatrics. 2003;3(1):e61–6.

    Article  Google Scholar 

  10. Hoffman HJ, Damus K, Hillman L, Krongrad E. Risk factors for SIDS Results of the National Institute of Child Health and Human Development SIDS Cooperative Epidemiologic Study. Ann N Y Acad Sci. 1988;533:13–30.

    Article  PubMed  CAS  Google Scholar 

  11. Martin J, Hamilton B, Sutton P, et al. Births: final data for 2004. NVSR Vol 55 Number 1. Hyattsville, MD: National Center for Health Statistics; 2006. p. 14–16.

    Google Scholar 

  12. Hollis BW, Wagner CL. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr. 2004;79:717–26.

    PubMed  CAS  Google Scholar 

  13. Bouillon R, Van Baelen H, DeMoor D. 25-Hydroxy-vitamin D and its binding protein in maternal and cord serum. J Clin Endocrinol Metab. 1977;45:679–84.

    Article  PubMed  CAS  Google Scholar 

  14. Markestad T, Aksnes L, Ulstein M, Aarskog D. 25-Hydroxyvitamin D and 1,25-dihydroxy vitamin D of D2 and D3 origin in maternal and umbilical cord serum after vitamin D2 supplementation in human pregnancy. Am J Clin Nutr. 1984;40:1057–63.

    PubMed  CAS  Google Scholar 

  15. Hollis BW, Pittard WB. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocrinol Metab. 1984;59:652–7.

    PubMed  CAS  Google Scholar 

  16. Waiters B, Godel JC, Basu TK. Perinatal vitamin D and calcium status of Northern Canadian mothers and their newborn infants. J Am Coll Nutr. 1998;18(1):122–6.

    Google Scholar 

  17. Harris SS, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr. 1998;67:1232–6.

    PubMed  CAS  Google Scholar 

  18. Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30:771–7.

    Article  PubMed  CAS  Google Scholar 

  19. Harris SS, Soteriades E, Coolidge JA, et al. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab. 2000;85:4125–30.

    Article  PubMed  CAS  Google Scholar 

  20. Harkness LS, Cromer BA. Vitamin D deficiency in adolescent females. J Adolesc Health. 2005;37:75.

    Article  PubMed  Google Scholar 

  21. Nesby-O’Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey 1988–1994. Am J Clin Nutr. 2002;76:187–92.

    PubMed  Google Scholar 

  22. Bodnar L, Simhan H, Powers R, et al. High prevalence of vitamin D insufficiency in Black and White pregnant women residing in the Northern United States and their neonates. J Nutr. 2007;137:447–52.

    PubMed  CAS  Google Scholar 

  23. Basile L, Taylor S, Wagner C, Quinones L, Hollis B. Neonatal vitamin D status at birth at latitude 32°72′: evidence of deficiency. J Perinatol. 2007;27(9):568–71.

    Article  PubMed  CAS  Google Scholar 

  24. Mannion CA, Gray-Donald K, et al. Association of low intake of milk and vitamin D during pregnancy with decreased birth weight. CMAJ. 2006;174(9):1273–7.

    PubMed  Google Scholar 

  25. Bibuld D, Johnson T, Young A. Is vitamin D a breakthrough for addressing health disparities? Presented at the American Public Health Association Annual Meeting and Exposition. Washington DC, Nov 2007.

  26. Brooke O, Brown I, Bone C, et al. Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J. 1980;280(6216):751–4. March 15.

    Article  PubMed  CAS  Google Scholar 

  27. Marya R, Rathee S, Lata V, Mudgil S. Effects of vitamin D supplementation in pregnancy. Gynecol Obstet Invest. 1981;12(3):155–61.

    PubMed  CAS  Google Scholar 

  28. Brooke O, Butters F, Wood C. Intrauterine vitamin D nutrition and postnatal growth in Asian infants. Br Med J. 1981;283:1024.

    Article  CAS  Google Scholar 

  29. Brunvand L, Quigstad E, Urdal P, Haug E. Vitamin D deficiency and fetal growth. Early Hum Dev. 1996;45(1–2):27–33.

    Article  PubMed  CAS  Google Scholar 

  30. Specker B. Vitamin D requirements during pregnancy. Am J Clin Nutr. 2004;80(Suppl):1740S–7S.

    PubMed  CAS  Google Scholar 

  31. Marya R, Rathee S, Dua V, Sangwan K. Effect of vitamin D supplementation during pregnancy on foetal growth. Indian J Med Res. 1988;88:488–92.

    PubMed  CAS  Google Scholar 

  32. National Center for Health Statistics, Health, United States, 2002 with chartbook on trends in the health of Americans. Hyattsville, MD: NCHS. http://www.cdc.gov/nchs/products/pubs/pubd/hus/02tables.html (2002). Accessed 21 Aug 2008.

  33. Chart 3-14 from Morbidity and Mortality: 2007 Chart Book on Cardiovascular, Lung, and Blood Diseases, published June 2007 by the National Institutes of Health, National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov/resources/doc/07-chtbk.pdf. Accessed 27 Mar 2009.

  34. Wang T, Pencina M, Booth S, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:1–9.

    Article  Google Scholar 

  35. Giovannucci E, Liu Y, Hollis B, Rimm E. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med. 2008;168(11):1174–80.

    Article  PubMed  CAS  Google Scholar 

  36. Zitterman A, Schleithoff S, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005;94:483–92.

    Article  CAS  Google Scholar 

  37. Targher G, Bertolini L, Paovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol. 2006;65:593–7.

    Article  CAS  Google Scholar 

  38. Melamed M, Muntner P, Michos E, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2008;28:1179–85.

    Article  PubMed  CAS  Google Scholar 

  39. Forman J, Giovannucci E, Holmes M, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–9.

    Article  PubMed  CAS  Google Scholar 

  40. Dobrig H, Pilz S, Schanargl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340–9.

    Article  Google Scholar 

  41. Melamed M, Michos E, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629–37.

    Article  PubMed  Google Scholar 

  42. Garland C, Garland F, Gorham D, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96(2):252–61.

    Article  PubMed  Google Scholar 

  43. Ries LAG, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975–2005, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER website, 2008. Accessed 2 Aug 2008.

  44. Percentage of adults who used cigars, pipes, chewing tobacco, snuff, or any form of tobacco by hispanic origin, race, and sex—1987,1991, 1992 (combined) and 1998 and 2000 (combined). CDC Website at http://www.cdc.gov/tobacco/data_statistics/tables/adult/table_9.htm. Accessed 2 Nov 2008.

  45. Prevalence of current smoking among adults aged 18 years and over: United States, 1997 September 2007. CDC at http://www.cdc.gov/tobacco/data_statistics/tables/adult/table_9.htm. Accessed 2 Nov 2008.

  46. American Cancer Society. Cancer Facts and Figures 2003. Atlanta: American Cancer Society; 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed 28 Mar 2009.

  47. Giovanucci E, Liu Y, Rimm E, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451–9.

    Article  Google Scholar 

  48. Giovannucci E, Liu Y, Willett W. Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2467–72.

    Article  PubMed  CAS  Google Scholar 

  49. Lapp J, Tavers-Gustafson D, Davies K, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586–91.

    Google Scholar 

  50. Zhou W, Heist R, Liu G, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007;25:479–85.

    Article  PubMed  CAS  Google Scholar 

  51. Garland C, Comstock G, Garland F, et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2:1176–8.

    Article  PubMed  CAS  Google Scholar 

  52. Gorham E, Garland C, Garland F, et al. Optimal vitamin D status for colorectal cancer prevention. A quantitative meta analysis. Am J Prev Med. 2007;32(3):210–6.

    Article  PubMed  Google Scholar 

  53. Sieg J, Sieg A, Dreyhaupt J, et al. Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis. Anticancer Res. 2007;26:2729–33.

    Google Scholar 

  54. Feskanich D, Ma J, Fuchs C, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1502–8.

    PubMed  CAS  Google Scholar 

  55. Knight J, Lesosky M, Barnett H, et al. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007;16(3):422–9.

    Article  PubMed  CAS  Google Scholar 

  56. Neuhouser M, Sorensen B, Hollis B, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr. 2008;88(1):133–9.

    PubMed  CAS  Google Scholar 

  57. American Cancer Society. Cancer Facts and Figures 2003. Atlanta: American Cancer Society; 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed 28 Mar 2009.

  58. Ahonen M, Tenkanen L, Teppo L, et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels. Cancer Causes Control. 2000;11(9):847–52.

    Article  PubMed  CAS  Google Scholar 

  59. John E, Koo J, Schwartz G. Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1283–6.

    Article  PubMed  Google Scholar 

  60. Li H, Stampfer M, Hollis B et al. A prospective study of plasma vitamin d metabolites, vitamin d receptor polymorphisms, and prostate cancer. PLoS Med 2007;4(3):0562–0571. www.plosmedicine.org. Accessed 4 July 2008.

    Google Scholar 

  61. Autier P, Gandine S. Vitamin D supplementation and total mortality. Arch Intern Med. 2007;17:1730–7.

    Article  Google Scholar 

  62. From the US Department of Health and Human Services, Office of Minority Health, Diabetes Data/Statistics. http://www.omhrc.gov/templates/browse.aspx?lvl=3&lvlid=62. Accessed 6 Nov 2008.

  63. http://www.cdc.gov/nchs/products. Accessed 5 Nov 2008.

  64. Scragg R, Chonchol M. 25-Hydroxy vitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007;71:134–9.

    Article  PubMed  CAS  Google Scholar 

  65. Chui K, Chu A, Go VLW, Saad M. Hypovitaminosis D is associated with insulin resistance and β-cell dysfunction. Am J Clin Nutr. 2004;79:820–5.

    Google Scholar 

  66. Boucher B, Mannan N, Noonan K, et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia. 1995;38:1239–45.

    Article  PubMed  CAS  Google Scholar 

  67. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001;24(8):1496.

    Article  PubMed  CAS  Google Scholar 

  68. Di Cesar D, Ploutz-Snyder R, Weinstock R, Moses A. Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care. 2006;29(1):174.

    Article  PubMed  Google Scholar 

  69. Borissova A, Tankova T, Kirilov G, et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003;57(4):258–61.

    PubMed  CAS  Google Scholar 

  70. Pittas A, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29(3):650–6.

    Article  PubMed  CAS  Google Scholar 

  71. Schwalfenberg G. Vitamin D and diabetes. Can Fam Physician. 2008;54:864–6.

    PubMed  Google Scholar 

  72. Brooke Steele C, Meléndez-Morales L, Campoluci R, De Luca N, Dean HD. Health disparities in HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis: issues, burden, and response, a retrospective review, 2000–2004. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, November 2007. Available at http://www.cdc.gov/nchhstp/healthdisparities/. Accessed 1 Nov 2008.

  73. Chan TYK. Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int. 2000;66:476–8.

    Article  PubMed  CAS  Google Scholar 

  74. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.

    Article  PubMed  CAS  Google Scholar 

  75. Wilkinson R, Llewelyn M, Toosi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000;355(9204):618–21.

    Article  PubMed  CAS  Google Scholar 

  76. Aloia JF, Li-Ng M. Correspondence: epidemic influenza and vitamin D. Epidemiol Infect. 2007;135(7):1095–8.

    Article  PubMed  Google Scholar 

  77. Wang T, Nestal F, Bourdeau V, et al. 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909–12.

    PubMed  CAS  Google Scholar 

  78. Sun L, Finnegan C, Kish-Catelone T, et al. Human β-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol. 2005;79:14318–29.

    Article  PubMed  CAS  Google Scholar 

  79. Chang TL, Francois F, Mosoian A, Klotman ME. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol. 2003;77:6777–84.

    Article  PubMed  CAS  Google Scholar 

  80. Chang TL, Vargas J Jr, DelPortillo A, Klotman ME. Dual role of α-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest. 2005;115:765–73.

    PubMed  CAS  Google Scholar 

  81. The health of Boston 2008. Boston Public Health Commission Research Office: Boston, MA; 2008.

Download references

Author information

Authors and Affiliations

  1. Mattapan Community Health Center, 1425 Blue Hill Avenue, Mattapan, MA, 02126, USA

    Douglass Bibuld

Authors
  1. Douglass Bibuld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglass Bibuld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bibuld, D. Health Disparities and Vitamin D. Clinic Rev Bone Miner Metab 7, 63–76 (2009). https://doi.org/10.1007/s12018-009-9039-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12018-009-9039-5

Keywords

Search

Navigation